Lois M. Witters
Department of Medicine
H046, Milton S. Hershey Medical Center
Hershey
USA
Name/email consistency: high
- Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor. Witters, L.M., Witkoski, A., Planas-Silva, M.D., Berger, M., Viallet, J., Lipton, A. Oncol. Rep. (2007)